COMMENTARY
 
TOPICS
REFERENCES (27)
1.
Shantsila E, Choi EK, Lane DA, Joung B, Lip GYH. Atrial fibrillation: comorbidities, lifestyle, and patient factors. Lancet Reg Health Eur 2024; 37: 100784.
 
2.
Ahn HJ, Han KD, Choi EK, et al. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study. Cardiovasc Diabetol 2021; 20: 20.
 
3.
Choi SH, Yang PS, Kim D, et al. Association of obesity with incident atrial fibrillation in Korea and the United Kingdom. Sci Rep 2023; 13: 5197.
 
4.
Krittayaphong R, Boonyapiphat T, Winijkul A, Lip GYH. Clinical outcomes of obese and nonobese patients with atrial fibrillation according to associated metabolic abnormalities: a report from the COOL-AF registry. J Diabetes 2024; 16: e13519.
 
5.
Corica B, Romiti GF, Proietti M, et al. Clinical outcomes in metabolically healthy and unhealthy obese and overweight patients with atrial fibrillation: findings from the GLORIA-AF Registry. Mayo Clin Proc 2024; 99: 927-39.
 
6.
Fauchier G, Bisson A, Bodin A, et al. Metabolically healthy obesity and cardiovascular events: a nationwide cohort study. Diabetes Obes Metab 2021; 23: 2492-501.
 
7.
Piqueras P, Ballester A, Durá-Gil JV, Martinez-Hervas S, Redón J, Real JT. Anthropometric indicators as a tool for diagnosis of obesity and other health risk factors: a literature review. Front Psychol 2021; 12: 631179.
 
8.
Proietti M, Guiducci E, Cheli P, Lip GY. Is there an obesity paradox for outcomes in atrial fibrillation? A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant trials. Stroke 2017; 48: 857-66.
 
9.
Oesch L, Tatlisumak T, Arnold M, Sarikaya H. Obesity paradox in stroke – myth or reality? A systematic review. PLoS One 2017; 12: e0171334.
 
10.
Antonopoulos AS, Tousoulis D. The molecular mechanisms of obesity paradox. Cardiovasc Res 2017; 113: 1074-86.
 
11.
Tracz J, Gorczyca-Głowacka I, Rosołowska A, Kołodziejska E, Wożakowska-Kapłon B. A worsened prognosis for patients after stroke with newly diagnosed atrial fibrillation compared to having a preexisting arrhythmia. Arch Med Sci 2022; DOI: https://doi.org/10.5114/aoms/1....
 
12.
Watanabe K, Okazaki S, Kitano T, et al. Stroke severity and outcomes in patients with newly diagnosed atrial fibrillation. Front Neurol 2021; 12: 666491.
 
13.
Doehner W, Boriani G, Potpara T, et al. Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association. Europace 2025; 27: euaf019.
 
14.
Elsheikh S, Hill A, Irving G, Lip GYH, Abdul-Rahim AH. Atrial fibrillation and stroke: state-of-the-art and future directions. Curr Probl Cardiol 2024; 49: 102181.
 
15.
Botto GL, Padeletti L, Santini M, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20: 241-8.
 
16.
Sposato LA, Chaturvedi S, Hsieh CY, Morillo CA, Kamel H. Atrial fibrillation detected after stroke and transient ischemic attack: a novel clinical concept challenging current views. Stroke 2022; 53: e94-103.
 
17.
Tao M, Wu Y, Cao H, Peng H. Trends in stroke prevalence caused by an elevated BMI in the European population. Arch Med Sci 2025. DOI: https://doi.org/10.5114/aoms/1....
 
18.
Weir CB, Jan A. BMI Classification Percentile And Cut Off Points. StatPearls. Treasure Island (FL) 2025.
 
19.
Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J 2013; 34: 268-77.
 
20.
Skolarus LE, Sanchez BN, Levine DA, et al. The association of body mass index and mortality after acute ischemic stroke. Circ Cardiovasc Qual Outcomes 2013; 7: 64-9.
 
21.
Mairesse GH, Moran P, Van Gelder IC, et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) - PubMed. Europace 2017; 19: 1589-623.
 
22.
Burdett P, Lip GYH. Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom. Eur Heart J Qual Care Clin Outcomes 2022; 8: 892-8.
 
23.
Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 2017; 14: 627-8.
 
24.
Chu M, Zhang S, Gong J, et al. Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial. Nat Med 2025; 31: 1276-85.
 
25.
Romiti GF, Guo Y, Corica B, et al. Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial. Thromb Haemostasis 2023; 123: 1042-8.
 
26.
Lip GYH, Lane DA, Lenarczyk R, et al. Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. Eur Heart J 2022; 43: 2442-60.
 
27.
Tsang CTW, Choi SE, Bucci T, et al. Integrated care using the ABC(stroke) pathway improves cardiovascular outcomes and survival in patients with first-ever ischaemic stroke. Global Heart 2025; 20: 46.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top